top
Search terms
Results 1 - 5 of 5 - ordered by :
Ehjournal

Applying our own recently published reference equations on these values would result in a peakVO2 of 170% as personally predicted (for a male subject of 25 years, 180 cm, 70 kg).2 Even the mean ...

European Heart Journal, Gläser, Sven, Schäper, Christoph, Ewert, Ralf, Koch, Beate

Date : 01/07/2009
Ehjournal

Even with the most effective treatment strategies, only 5060% of patients survive >5 years.13 Since the reports describing beneficial effects of continuous intravenous (i.v.) epoprostenol on ...

European Heart Journal, Opitz, Christian F., Wensel, Roland, Winkler, Jörg, Halank, Michael, Bruch, Leonhard, Kleber, Franz-Xaver, Höffken, Gert, Anker, Stefan D., Negassa, Abdissa, Felix, ...

Date : 01/09/2005
Ehjournal

Applying our own recently published reference equations on these values would result in a peakVO2 of 170% as personally predicted (for a male subject of 25 years, 180 cm, 70 kg).2 Even the mean ...

European Heart Journal, Gläser, Sven, Schäper, Christoph, Ewert, Ralf, Koch, Beate

Date : 01/07/2009
Ehjournal

A clinically meaningful difference among the three approved ETRAs with respect to their ET-receptor selectivity could not be demonstrated to date. [...]in clinical practice, other features are ...

European Heart Journal, Opitz, Christian F., Ewert, Ralf, Kirch, Wilhelm, Pittrow, David

Date : 01/08/2008 Item size : 502423 bytes
Ehjournal

Even with the most effective treatment strategies, only 5060% of patients survive >5 years.13 Since the reports describing beneficial effects of continuous intravenous (i.v.) epoprostenol on ...

European Heart Journal, Opitz, Christian F., Wensel, Roland, Winkler, Jörg, Halank, Michael, Bruch, Leonhard, Kleber, Franz-Xaver, Höffken, Gert, Anker, Stefan D., Negassa, Abdissa, Felix, ...

Date : 01/09/2005